PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
-25.63%
Negative ROE indicates either losses or negative equity – a major Benjamin Graham warning. Confirm if leverage or poor profitability is the cause.
-11.45%
Negative ROA indicates net losses or excessive assets. Benjamin Graham would question viability or capital misallocation.
-14.18%
Negative ROCE suggests negative EBIT or an inflated capital base. Benjamin Graham would check if the firm is structurally unprofitable.
-145.68%
Negative gross margin indicates the cost of goods sold exceeds revenue – a drastic red flag for Benjamin Graham. Investigate pricing or cost structure.
-12769.14%
Negative operating margin means operating expenses exceed gross profit – a classic Benjamin Graham red flag. Investigate cost structure or revenue viability.
-11511.11%
Negative net margin indicates net losses. Benjamin Graham would caution about solvency and capital reserves.